AMO concludes Pfizer acquisition

Advanced Medical Optics Inc. (AMO) completed its previously announced $450 million all-cash acquisition of Pfizer Ophthalmic's surgical business.

Related Videos

Related Content

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

September 28th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 27th 2023

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Related Content

Advertisement

---

Digital healthcare startup eyecbetter kicks off Regulation C crowdfunding campaign on StartEngine

Article

---

EyePod: Transforming the MIGS pipeline into clinical reality

Podcast

---

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

Article

---

EyePod: Week in Review - September 17, 2023

Podcast

---

ProQR Therapeutics offers update on sale of ophthalmic assets

Article

---

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

Article